Alpine Immune Sciences - GSNOR Unit's Unit Acquisition

Alpine Immune Sciences - GSNOR Unit raised a round of funding on July 20, 2018. Investors include Laurel Venture Capital.

Alpine Immune Sciences uses proprietary variant immunoglobulin domain (vIgD) platform technology – designed to interact with multiple targets simultaneously in the immune synapse using a single mole…

Articles about Alpine Immune Sciences - GSNOR Unit's Unit Acquisition: